Neuromodulation Market by Product and Geography - Forecast and Analysis 2020-2024

神経調節の世界市場:予測及び分析 2020-2024

◆タイトル:Neuromodulation Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード:IRTNTR40310
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年12月
◆ページ数:167
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本レポートは、神経調節の市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別(埋め込み型神経調節デバイス、外部神経調節デバイス)分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。
・エグゼクティブサマリー
・レポートの範囲
・市場状況
・市場規模
・ファイブフォース分析
・神経調節の世界市場:製品別(埋め込み型神経調節デバイス、外部神経調節デバイス)
・顧客状況
・地域別状況
・意思決定フレームワーク
・市場の要因と課題
・市場動向
・企業状況
・企業分析

Global Neuromodulation Market: About this market
Technavio’s neuromodulation market analysis considers sales from implantable neuromodulation devices and external neuromodulation devices. Our study also finds the sales of neuromodulation in Asia, Europe, North America, and ROW. In 2019, the implantable neuromodulation devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as technological advances and new product launches will play a significant role in the implantable neuromodulation devices segment to maintain its market position. Also, our global neuromodulation market report looks at factors such as increasing prevalence of chronic diseases and related risk factors, increasing awareness initiatives and access to healthcare, and technological advances. However, high cost of devices and procedures, device limitations and complications, and stringent regulations may hamper the growth of the neuromodulation industry over the forecast period.

Global Neuromodulation Market: Overview
Technological advances
Technological advances related to battery longevity and miniaturization of implantable neuromodulation devices, including the circuitry and battery, device software and programming, introduction of rechargeable batteries, and implantation techniques, have significantly improved the reliability and effectiveness of neuromodulation devices. One of the latest technological advances in neuromodulation devices has been the development of MRI-conditional implantable neuromodulation devices. Such technological advances will lead to the expansion of the global neuromodulation market at a CAGR of over 11% during the forecast period.

Expanding indications
Several neuromodulation devices have recently received approval for indications and are ongoing clinical trials to explore their additional therapeutic properties. Some new indications that are currently being investigated for neuromodulation therapy include Alzheimer’s, heart failure, stroke recovery, diabetic neuropathy, migraine headaches, refractory angina relief, hypertension, chronic respiratory insufficiency, and gastrointestinal disorders. Historically, neuropathic pain conditions have been difficult to treat as the pain stem from tissue and nerve damages or result from a disruption in how the peripheral and central nervous system processes or transmit pain signals. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global neuromodulation market during the forecast period 2020-2024, click here.

Competitive Landscape
With the presence of several major players, the global neuromodulation market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuromodulation manufacturers, that include Abbott Laboratories, Boston Scientific Corp., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., Neuronetics Inc., Nevro Corp., Nuvectra Co., OMRON Corp., and Zynex Inc.
Also, the neuromodulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market Outlook
• Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Implantable neuromodulation devices – Market size and forecast 2019-2024
• External neuromodulation devices – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Improving reimbursement policies
• Strategic collaborations and acquisitions
• Expanding indications
• PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Boston Scientific Corp.
• LivaNova Plc
• Medtronic Plc
• NeuroMetrix Inc.
• Neuronetics Inc.
• Nevro Corp.
• Nuvectra Co.
• OMRON Corp.
• Zynex Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Implantable neuromodulation devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Implantable neuromodulation devices – Year-over-year growth 2020-2024 (%)
Exhibit 22: External neuromodulation devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: External neuromodulation devices – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott Laboratories – Vendor overview
Exhibit 47: Abbott Laboratories – Business segments
Exhibit 48: Abbott Laboratories – Organizational developments
Exhibit 49: Abbott Laboratories – Geographic focus
Exhibit 50: Abbott Laboratories – Segment focus
Exhibit 51: Abbott Laboratories – Key offerings
Exhibit 52: Boston Scientific Corp. – Vendor overview
Exhibit 53: Boston Scientific Corp. – Business segments
Exhibit 54: Boston Scientific Corp. – Organizational developments
Exhibit 55: Boston Scientific Corp. – Geographic focus
Exhibit 56: Boston Scientific Corp. – Segment focus
Exhibit 57: Boston Scientific Corp. – Key offerings
Exhibit 58: LivaNova Plc – Vendor overview
Exhibit 59: LivaNova Plc – Product segments
Exhibit 60: LivaNova Plc – Organizational developments
Exhibit 61: LivaNova Plc – Geographic focus
Exhibit 62: LivaNova Plc – Segment focus
Exhibit 63: LivaNova Plc – Key offerings
Exhibit 64: Medtronic Plc – Vendor overview
Exhibit 65: Medtronic Plc – Business segments
Exhibit 66: Medtronic Plc – Organizational developments
Exhibit 67: Medtronic Plc – Geographic focus
Exhibit 68: Medtronic Plc – Segment focus
Exhibit 69: Medtronic Plc – Key offerings
Exhibit 70: NeuroMetrix Inc. – Vendor overview
Exhibit 71: NeuroMetrix Inc. – Business segments
Exhibit 72: NeuroMetrix Inc. – Organizational developments
Exhibit 73: NeuroMetrix Inc. – Key offerings
Exhibit 74: Neuronetics Inc. – Vendor overview
Exhibit 75: Neuronetics Inc. – Business segments
Exhibit 76: Neuronetics Inc. – Organizational developments
Exhibit 77: Neuronetics Inc. – Geographic focus
Exhibit 78: Neuronetics Inc. – Key offerings
Exhibit 79: Nevro Corp. – Vendor overview
Exhibit 80: Nevro Corp. – Business segments
Exhibit 81: Nevro Corp. – Organizational developments
Exhibit 82: Nevro Corp. – Geographic focus
Exhibit 83: Nevro Corp. – Key offerings
Exhibit 84: Nuvectra Co. – Vendor overview
Exhibit 85: Nuvectra Co. – Business segments
Exhibit 86: Nuvectra Co. – Organizational developments
Exhibit 87: Nuvectra Co. – Geographic focus
Exhibit 88: Nuvectra Co. – Key offerings
Exhibit 89: OMRON Corp. – Vendor overview
Exhibit 90: OMRON Corp. – Business segments
Exhibit 91: OMRON Corp. – Organizational developments
Exhibit 92: OMRON Corp. – Geographic focus
Exhibit 93: OMRON Corp. – Segment focus
Exhibit 94: OMRON Corp. – Key offerings
Exhibit 95: Zynex Inc. – Vendor overview
Exhibit 96: Zynex Inc. – Business segments
Exhibit 97: Zynex Inc. – Organizational developments
Exhibit 98: Zynex Inc. – Key offerings
Exhibit 99: Validation techniques employed for market sizing
Exhibit 100: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories, Boston Scientific Corp., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., Neuronetics Inc., Nevro Corp., Nuvectra Co., OMRON Corp., and Zynex Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[神経調節の世界市場:予測及び分析 2020-2024]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆